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RVD of 2.6 mm and a mean lumen obstruction of 66.1%. Pre-dilatation
was performed in 94% and post-dilatation in 59%. The mean scaffold
length was 27.4 mm with 36% of cases using 2 stents and 26% of
cases using overlapping scaffolds. OCT or IVUS was used in 30%.
Device success was 98.0% (failure to expand in 1 pts. and deliver in 5
pts.). Over the entire follow-up period, death occurred in 1.7% (5/297),
myocardial infarction (MI) in 2.7% (total of 8 cases, 1 of peri-proce-
dural), target lesion revascularization in 3.4%, target vessel revascu-
larization (TVR) in 4.7%, non-target vessel revascularization 1.3%.
Deﬁnite stent thrombosis (ST) occurred in 6 pts. (2.0%) and probable
ST in 1 pt. (0.3%); all ST were early including one acute ST except of
two case of deﬁnite ST which occurred at days 40 and 84, respec-
tively. Overall MACE (death, MI, TVR) rate was 6.4% (19/297).
CONCLUSIONS This registry including patients with ACS and com-
plex lesion characteristics documents a good safety and efﬁcacy pro-
ﬁle of the BVS. However, stent thrombosis rates in particular early
after BVS implantation have to be closely monitored. More data
including complex patient and lesion subsets as well as longer follow-
ups are needed to deﬁne the role of BVS in daily practice.
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BACKGROUND Tissue formation at coronary bifurcations is related to
vascular endothelial shear stress, and postmortem pathological
studies have described different patterns of neointimal coverage be-
tween the outer wall and inner wall at coronary bifurcations treated
with ﬁrst-generation drug-eluting stents (DES). Current everolimus-
eluting bioresorbable scaffolds (BRS) have thicker struts compared to
their metallic counterparts, and could therefore have a stronger in-
ﬂuence on vascular endothelial shear stress compared to DES. How-
ever, the neointimal coverage of bifurcation lesions treated with BRS
has not been adequately studied. In the current study, we sought to
evaluate the vascular response to BRS struts deployed at bifurcation
segments using optical coherence tomography (OCT).
METHODS This study included 37 patients (51 bifurcation lesions)
examined with coronary angiography including OCT 11.0  2.1 months
after BRS implantation. Cross-sectional area (CSA) of the bifurcation
lesion with a side branch more than 1mm using OCT were analyzed
every 200mm. All images were divided into 3 regions according to the
shear stress: one half of the circumference of the vessel opposite to
the ostium (OO), the side branch ostium (SO), and the vessel wall
adjacent to the ostium (AO). All struts in OO, AO, and SO regions were
classiﬁed as covered or uncovered. The thickness of coverage was
measured in each CSA, and the averaged neointimal thickness (NIT)
was calculated. Additionally, to evaluate the impact of the side branch
size on neointimal proliferation, we classiﬁed side branches according
to the ratio of the diameter of the side branch ostium (Ds) to the
diameter of main branch (Dm).
RESULTS The mean age of the study population was 5711 years.
Mean BRS diameter and length were 3.10.37 and 21.05.7mm,
respectively. The mean diameter of all side branches was
1.590.55mm. Overall, there was a signiﬁcant difference in NIT among
the 3 examined regions (OO, 11968 vs. AO, 9435 vs. SO, 8041mm,
p¼0.03). In addition, a signiﬁcant difference was observed in the
percentage of uncovered struts among the 3 regions (OO, 0.43 vs. AO,
1.4 vs. SO, 4.8%, p¼0.02). Lesions were divided into 2 groups based on
a median value of Ds/Dm of 0.318 (large ratio side branch group ¼
LRSB, n¼26; and small ratio side branch group ¼ SRSB, n¼25). In the
LRSB group, there was a signiﬁcant difference in NIT (OO, 12861 vs.
AO, 913.6 vs. SO, 7438 mm, p¼0.01) and in the percentage of un-
covered struts (OO, 0.38 vs. AO, 2.0 vs. SO, 8.7%, p¼0.01) between the
3 regions, but this was not observed in the SRSB group.
CONCLUSIONS Different patterns of neointimal coverage are
observed between the outer wall and inner wall of coronary bifurca-
tion lesions treated with everolimus-eluting BRS. Neointimal
coverage is least at and adjacent to large side branches.CATEGORIES CORONARY: Bioresorbable Vascular Scaffolds
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BACKGROUND Degradation of bioresorbable stents (BRS) has been
shown to allow restoration of the treated segment’s plasticity and
reactivity to those resembling a non-stented artery, a desirable feature
unattainable with metallic stents (BMS). We have previously reported
the dynamic changes in arterial geometry in response to a novel non-
drug eluting BRS as compared to BMS up to 2 years. This study pro-
vides an insight over a 3-year duration.
METHODS Forty-seven coronary arteries of 19 swine received BRS
(Amaranth Medical, Mountain View, CA n¼34) or BMS (Liberte Bos-
ton Scientiﬁc, Natick, MA n¼13). Optical coherence tomography (OCT)
was done at day 0, 1 month (BRS, n¼26; BMS, n¼13), 1 year (BRS, n¼12;
BMS, n¼4), 2 years (BRS, n¼13; BMS, n¼4) and 3 years post implant
(BRS, n¼11; BMS, n¼3).
RESULTS The lumen areas of reference segments increased over time in
both BMS-caged segments (Day 0¼6.091.80mm2, 2 Years¼10.55
2.95mm2 and 3 Years¼13.583.23mm2, p<0.05) and the BAS-treated
arteries (Day 0¼6.631.21mm2, 2 Years¼11.632.30mm2 and 3
Years¼12.162.72mm2,p<0.05).BMSshowed lumenarea loss at 1monthas
expected due to neointimal formation, and then minimal lumen area
variance over time up to 3 years (Day 0¼6.791.7mm2, 2
Years¼6.782.25mm2, and3years¼7.371.83mm2,p>0.05). In contrast, in
BAS the early lumen area loss present at 1 month inverted into lumen gain
that corresponded with the scaffold expansion as it degraded, paralleling
the artery growth (scaffold area, Day 0¼6.871.17mm2, 2
Years¼11.661.51mm2, and 3 years¼13.872.75 mm2, p<0.05) and allow-
ing the treated segment to remodel (lumen area, Day 0¼6.871.17mm2, 2
Years¼9.671.56mm2, and 3 years¼11.942.77mm2, p<0.05, Figure). %
Area Stenosis did not show signiﬁcant difference between BMS and BRS
over time.
CONCLUSIONS Between 2 and 3 years after implantation, BRS treated
coronary artery segments continue to positively remodel, with further
late lumen area gain paralleling the reference segment expansion over
time. This pattern, uniquely possible due to scaffold degradation and
unattainable in the BMS-caged segments, appears to be a reproducible
and inherent behavior of non-drug eluting bioresorbable stents in the
normal porcine coronary model.
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